![Ian Clark](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Clark
Chairman at
OLEMA PHARMACEUTICALS, INC.
Net worth: 3 M $ as of 30/05/2026
Profile
Ian T.
Clark is currently Chairman at X-Vax Technology, Inc., Olema Pharmaceuticals, Inc., and will be Chairman at BioMarin Pharmaceutical, Inc. starting in 2026.
Mr. Clark serves as Lead Independent Director at Guardant Health, Inc., Independent Director at Corvus Pharmaceuticals, Inc. and Kyverna Therapeutics, Inc. (title starting 2026), Director at Asher Biotherapeutics, Inc., and Member at TechNet.
Former roles include Chief Executive Officer & Director at Genentech, Inc. from 2010 to 2016, Independent Director at TerraVia Holdings, Inc. from 2012 to 2017, Independent Non-Executive Director at Shire Plc from 2017 to 2019, Independent Director at Agios Pharmaceuticals, Inc. from 2016 to 2022, Director at Shire Pharmaceuticals, Inc. from 2017 to 2019, Independent Director at Forty Seven LLC from 2018 to 2020, Independent Director at AVROBIO, Inc. from 2018 to 2024, Independent Director at GoodRx Holdings, Inc. from 2024 to 2026, Independent Director at Takeda Pharmaceutical Co., Ltd. from 2019 to 2026, Chief Operating Officer at Novartis Pharmaceuticals UK Ltd. from 1999 to 2001, General Manager at Novartis Pharmaceuticals Canada, Inc. from 2001 to 2003, Chief Marketing Officer & Executive Vice President at Roche Group in 2009, Director at Dendreon Corp.
and Dendreon Pharmaceuticals LLC from 2009 to 2010, and Vice President-Sales & Marketing roles at IVAX LLC, Aventis SA, and Sanofi.
Education includes undergraduate studies at The University of Southampton.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/06/2026 | 8,067 ( 0.01% ) | 1 M $ | 30/05/2026 | |
| 01/06/2026 | 14,490 ( 0.01% ) | 830 132 $ | 30/05/2026 | |
| 17/03/2026 | 19,396 ( 0% ) | 623 586 $ | 30/05/2026 | |
| 07/07/2025 | 100,150 ( 0.1% ) | 292 438 $ | 30/05/2026 | |
| 26/05/2026 | 21,727 ( 0.04% ) | 185 114 $ | 30/05/2026 | |
| 17/06/2026 | 0 ( -.--% ) | - $ | 30/05/2026 | |
| 10/06/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
Ian Clark active positions
| Companies | Position | Start |
|---|---|---|
| CORVUS PHARMACEUTICALS, INC. | Director/Board Member | 02/01/2017 |
| GUARDANT HEALTH, INC. | Director/Board Member | 30/11/2016 |
| OLEMA PHARMACEUTICALS, INC. | Chairman | 31/07/2020 |
| KYVERNA THERAPEUTICS, INC. | Director/Board Member | 11/01/2026 |
| BIOMARIN PHARMACEUTICAL INC. | Chairman | 01/06/2026 |
X-Vax Technology, Inc.
 X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products | Chairman | - |
Asher Biotherapeutics, Inc.
 Asher Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies | Director/Board Member | 13/02/2022 |
TechNet
 TechNet Miscellaneous Commercial ServicesCommercial Services Operates as a bipartisan policy and political network technology | Corporate Officer/Principal | - |
Former positions of Ian Clark
| Companies | Position | End |
|---|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Director/Board Member | 23/06/2026 |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Ian Clark
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
38
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 38 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
IVAX LLC
 IVAX LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures & markets branded and generic pharmaceuticals | Health Technology |
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Aventis SA
 Aventis SA Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and vaccines for preventative medicine | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
TerraVia Holdings, Inc.
 TerraVia Holdings, Inc. Household/Personal CareConsumer Non-Durables Manufactures and sells food, nutrition and specialty ingredients from algae | Consumer Non-Durables |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
Guardant Health, Inc.
 Guardant Health, Inc. Medical SpecialtiesHealth Technology Develops blood and tissue test devices to detect cancer & provides related screening services | Health Technology |
Corvus Pharmaceuticals, Inc.
 Corvus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides anticancer immuno-oncology drugs | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines and drugs | Health Technology |
Roche Group
 Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVAX Pharmaceuticals, Inc.
 IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
TechNet
TechNet Miscellaneous Commercial ServicesCommercial Services Operates as a bipartisan policy and political network technology | Commercial Services |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The J. David Gladstone Institutes
 The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology | Commercial Services |
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services Operates as a association to encourage and promote bioscience sector | Commercial Services |
Forty Seven, Inc.
 Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Vernalis (R&D) Ltd.
 Vernalis (R&D) Ltd. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Gladstone Foundation (CA)
 Gladstone Foundation (CA) Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit life science research organization that focuses on biomedical and technological fields | Commercial Services |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
Vernalis Therapeutics, Inc.
 Vernalis Therapeutics, Inc. Medical DistributorsDistribution Services Distributes pharmaceutical products | Distribution Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Dendreon Pharmaceuticals LLC
 Dendreon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets immunotherapies | Health Technology |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies | Health Technology |
Kyverna Therapeutics, Inc.
 Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
GoodRx Holdings, Inc.
 GoodRx Holdings, Inc. Medical/Nursing ServicesHealth Services Operates as an online telemedicine platform | Health Services |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
Solazyme, Inc. | |
Economic Advisory Council |
- Stock Market
- Insiders
- Ian Clark
